Cargando…
Determination of dose enhancement caused by AuNPs with Xoft(®) Axxent(®) Electronic (eBx™) and conventional brachytherapy: in vitro study
PURPOSE: The purpose of this study was to determine dose enhancement (DE) and the possible clinical benefits associated with the inclusion of gold nanoparticles (AuNPs) in cancer cells irradiated by either an (192)Ir brachytherapy source or a Xoft(®) Axxent(®) Electronic (eBx™) Brachytherapy. PATIEN...
Autores principales: | Shahhoseini, Elham, Ramachandran, Prabhakar, Patterson, William Roy, Geso, Moshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165788/ https://www.ncbi.nlm.nih.gov/pubmed/30310276 http://dx.doi.org/10.2147/IJN.S174624 |
Ejemplares similares
-
Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent® eBx® System for the management of early stage breast cancer in Taiwan
por: Lai, Hung-Wen, et al.
Publicado: (2017) -
Intraoperative radiation therapy in the treatment of early-stage breast cancer utilizing xoft axxent electronic brachytherapy
por: Dickler, Adam, et al.
Publicado: (2009) -
Calculated and measured radiation dose for the low energy xoft axxent eBT X-ray source
por: Can, Sümeyra, et al.
Publicado: (2023) -
Comparison of tumor and normal tissue dose for accelerated partial breast irradiation using an electronic brachytherapy eBx source and an Iridium‐192 source
por: Ahmad, Salahuddin, et al.
Publicado: (2010) -
AuNPs for identification of molecular signatures of resistance
por: Veigas, Bruno, et al.
Publicado: (2014)